Lee-Gannon, Theo
Jiang, Xuan
Tassin, Tara C.
Mammen, Pradeep P. A.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL102478)
National Institute of Child Health and Human Development (U54HD087351, P50HD087351)
University of Texas Southwestern Medical Center (UT Southwestern Alfred W. Harris, M.D. Professorship in Cardiology)
Article History
Accepted: 24 January 2022
First Online: 7 April 2022
Declarations
:
: Dr. Pradeep Mammen declares the following conflicts of interests: American Heart Association (AHA) (member of the AHA Career Development Research Grant Committee), California Institute of Regenerative Medicine (member of the Grants Working Group), CareDx Inc. (Site PI for the SHORE Registry), Catabasis Inc. (research grant), NIH (research grants and ad hoc grant reviewer for the NIH MOSS, SMEP, and TDPS Study Sections), Dyne Therapeutics (scientific consultant and member of the Scientific DMD Advisory Board), Novartis Gene Therapies Inc. (member of the Data Monitoring and Safety Committee), PhaseBio Inc. (research grant and member of the Scientific Advisory Board), and Revidia Therapeutics Inc. (member of the Scientific Advisory Board). The other authors have declared that no conflicts of interest exist as it pertains to the subject of the current study.
: This article does not contain any studies with human or animal subjects performed by any of the authors.